Search Results - "Shiff, Natalie"

Refine Results
  1. 1

    Pharmacosurveillance in Juvenile Idiopathic Arthritis by Shiff, Natalie J., Beukelman, Timothy

    “…The advent of biologic disease-modifying antirheumatic drugs targeting specific cytokines or cell-cell interactions has dramatically changed the outlook of…”
    Get full text
    Journal Article
  2. 2

    Trends in Population‐Based Incidence and Prevalence of Juvenile Idiopathic Arthritis in Manitoba, Canada by Shiff, Natalie J., Oen, Kiem, Kroeker, Kristine, Lix, Lisa M.

    Published in Arthritis care & research (2010) (01-03-2019)
    “…Objective To estimate the incidence and prevalence of juvenile idiopathic arthritis (JIA) in children ages <16 years in the province of Manitoba, Canada, and…”
    Get full text
    Journal Article
  3. 3

    Effectiveness and Safety of High‐Dose Biologics in Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance by Correll, Colleen K., Shrader, Peter, Dennos, Anne, Phillips, Thomas, Shiff, Natalie J., Verstegen, Ruud H. J., Beukelman, Timothy

    Published in Arthritis care & research (2010) (01-11-2022)
    “…Objective To describe high‐dose biologic use when treating juvenile idiopathic arthritis (JIA). Methods Patients with JIA enrolled in the Childhood Arthritis…”
    Get full text
    Journal Article
  4. 4

    Predicting Which Children with Juvenile Idiopathic Arthritis Will Have a Severe Disease Course: Results from the ReACCh-Out Cohort by Guzman, Jaime, Henrey, Andrew, Loughin, Thomas, Berard, Roberta A, Shiff, Natalie J, Jurencak, Roman, Benseler, Susanne M, Tucker, Lori B

    Published in Journal of rheumatology (01-02-2017)
    “…We studied an inception cohort of children with juvenile idiopathic arthritis (JIA) to (1) identify distinct disease courses based on changes over 5 years in 5…”
    Get full text
    Journal Article
  5. 5

    Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry by Tesser, John, Lin, Iris, Shiff, Natalie J., Chakravarty, Soumya D., Schmajuk, Gabriela, Hammam, Nevin, Desai, Sheetal

    Published in Clinical rheumatology (01-08-2022)
    “…Infliximab and golimumab are intravenously (IV) administered tumor necrosis factor inhibitors approved to treat moderate-to-severe rheumatoid arthritis (RA)…”
    Get full text
    Journal Article
  6. 6

    Validation of administrative health data for the pediatric population: a scoping review by Shiff, Natalie J, Jama, Sadia, Boden, Catherine, Lix, Lisa M

    Published in BMC health services research (22-05-2014)
    “…The purpose of this research was to perform a scoping review of published literature on the validity of administrative health data for ascertaining health…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Unpacking Early Work Experiences of Young Adults With Rheumatic Disease: An Examination of Absenteeism, Job Disruptions, and Productivity Loss by Jetha, Arif, Badley, Elizabeth, Beaton, Dorcas, Fortin, Paul R., Shiff, Natalie J., Gignac, Monique A. M.

    Published in Arthritis care & research (2010) (01-09-2015)
    “…Objective To examine work absenteeism, job disruptions, and perceived productivity loss and factors associated with each outcome in young adults living with…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early and Late Disease Through One Year of the GO-ALIVE Study by Deodhar, Atul A., Shiff, Natalie J., Gong, Cinty, Hsia, Elizabeth C., Lo, Kim Hung, Kim, Lilliane, Xu, Stephen, Reveille, John D.

    Published in Journal of clinical rheumatology (01-08-2022)
    “…This post hoc analysis assessed efficacy and safety of intravenous (IV) golimumab in ankylosing spondylitis (AS) patients with early disease (ED) versus late…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post hoc Analyses of Two Phase 3 Trials by Curtis, Jeffrey R., Deodhar, Atul, Soriano, Enrique R., Rampakakis, Emmanouil, Shawi, May, Shiff, Natalie J., Han, Chenglong, Tillett, William, Gladman, Dafna D.

    Published in Rheumatology and therapy. (01-12-2024)
    “…Introduction Patterns of treatment response can inform clinical decision-making. This study assessed the course and impact of achieving minimal clinically…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20